Obesity and asthma: risk, control and treatment

Monika Marko; Rafał Pawliczak

doi:10.5114/ada.2018.77607

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2018
vol. 35

Send email

Copy url:

abstract:

Review paper

Obesity and asthma: risk, control and treatment

Monika Marko

,

Rafał Pawliczak

Adv Dermatol Allergol 2018; XXXV (6): 563-571

DOI: https://doi.org/10.5114/ada.2018.77607

Online publish date: 2018/08/13

View full text Get citation

Asthma and obesity are currently one of the most common diseases. Observing an increase in morbidity of obesity and asthma, it can be concluded that there is a link between these diseases. But the mechanism of this relation is not well known. Due to reduced movement in patients and treatment, asthma is conducive to obesity, and obesity can exacerbate the symptoms associated with asthma. Obesity can affect bronchial hyperresponsiveness. Increasing body fat in obese people leads to systemic inflammation and elevated serum levels of many proinflammatory cytokines (e.g. leptin) and anti-inflammatory ones (e.g. adiponectin) that can have a causal relationship to bronchial asthma, but human studies are ambiguous. Obese asthmatics are characterized by a phenotype: heavier asthma, worse response to treatment and control of asthma. It has been found that in obese people, weight loss reduces the severity of asthma symptoms, so in these patients, treatment should include weight control.

keywords:

Obesity and asthma: risk, control and treatment

Monika Marko , Rafał Pawliczak

body mass index, obesity, asthma, control, treatment

Monika Marko

,

Rafał Pawliczak